Tiffany Mayo, MD
Enriched profileAssociate Professor of Dermatology; Director, Dermatology Clinical Research Unit · University of Alabama at Birmingham (UAB)
Tiffany Mayo is Associate Professor of Dermatology; Director, Dermatology Clinical Research Unit at University of Alabama at Birmingham (UAB). OpenAlex indexes 95 publications with 330 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 16 Oct 2026
Tiffany Mayo is Associate Professor of Dermatology at University of Alabama at Birmingham (UAB), Department of Dermatology. The public record shows 95 publications with 330 citations (h-index 11), centered on Acne / Hidradenitis, Atopic Dermatitis / Eczema. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · American journal of clinical dermatology
- Top research focus: Acne / Hidradenitis
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Sponsor: University of Alabama at Birmingham
- Bodewell Products for the Treatment of Atopic Dermatitis
Sponsor: University of Alabama at Birmingham
Industry payments
Updated 16 Oct 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202513 payments$25,693openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year202515 payments$12,616openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20259 payments$12,242openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.2%Azole Antifungal15.9%Ketoconazole100%Part D≥16 patientsLincosamide Antibacterial9.9%Clindamycin Phosphate100%Part D≥12 patients+ 1 more class in this area
Dermatology
22.9%Interleukin-4 Receptor alpha Antagonist11.5%Dupixent Pen68%Dupixent Syringe32%Part D<11 patientsCorticosteroid11.5%Triamcinolone Acetonide71%Halobetasol Propionate30%Part D<11 patientsCancer & immunology
16.1%TNF inhibitor8.6%Remicade64%Humira(Cf) Pen36%Part D<11 patientsKinase inhibitor4.2%Opzelura100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium.
American journal of clinical dermatology
Article2026 - Topical crisaborole is an efficacious steroid-sparing agent for treating mild-to-moderate seborrhoeic dermatitis.
Journal of the European Academy of Dermatology and Venereology
Letter2020
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tiffany-mayo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/tiffany-mayo-ms-md-87749b80
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Tiffany-Mayo
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/UABMedicine/videos/join-us-as-we-talk-live-with-tiffany-mayo-md-and-her-patient-anye-about-the-cool/2216965765002647
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/p/DQZkSEaDgTR
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
2026.acrpnet.org/mayo-tiffany
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2026.acrpnet.org ↗ - Other
skinofcolorsociety.org/events/dr-profiles/tiffany-mayo
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →skinofcolorsociety.org ↗ - Other
ajmc.com/authors/tiffany-mayo-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗ - Other
dermatologytimes.com/authors/tiffany-mayo-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗ - Other
hcplive.com/view/skin-of-color-savvy-hs-management-skin-of-color-tiffany-mayo-md-steven-daveluy-md-jasmine-ivanna-espy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - Other
uab.edu/news/working-with-us/experts/mayo-tiffany
- X / Twitter
visualdx.com/blog/an-interview-with-impact-leader-tiffany-mayo-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →visualdx.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Skinofcolorsociety.org
Skin of Color Society member profile/speaker page
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →skinofcolorsociety.org ↗ - LinkedIn
LinkedIn profile: Tiffany Mayo MS, MD - University of Alabama at Birmingham
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Baylor College of Medicine, Houston, TX
- M.S. in Chemistry
Tuskegee University
- B.S. in Chemistry
Tuskegee University
- Internal Medicine internship
McGaw Medical Center of Northwestern University, Chicago, IL
- Dermatology residency
University of Alabama at Birmingham School of Medicine
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Director
Dermatology Clinical Research Unit, UAB
- Leads Ethnic Skin and Hair Clinic
UAB Dermatology
Awards & honors
honors on the public recordSecondary affiliations
appointments beyond the home institution- Affiliated provider
Birmingham VA Medical Center (per third-party physician directory; not independently confirmed on a second source)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →visualdx.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Jeffrey Curtis, MD
University of Alabama at Birmingham (UAB)
Orlando Gutierrez, MD
University of Alabama at Birmingham (UAB)
Pankaj Arora, MD
University of Alabama at Birmingham (UAB)
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania